• 作者：M. Sá ; nchez-Pulgarí ; n ; ^{m.sanchezpulgarin@gmail.com} ; J.M. Martí ; nez-de-la-Casa ; A. Escalada ; F. Sá ; enz-Francé ; s ; J. Garcí ; a-Feijoó ; J. Garcí ; a Sá ; nchez
• 关键词：Glaucoma ; Cumplimiento ; Calidad de vida
• 刊名：Archivos de la Sociedad Espa帽ola de Oftalmolog铆a
• 出版年：2011
• 期刊代码：pca66_03656691
• 类别：med
• 出版时间：September 2011
• 卷：86
• 期：9
• 页码：282-286
• 文件大小：199 K

Purpose

To study compliance in the medical treatment of glaucoma, its possible association with other factors, and quality of life of patients with glaucoma.

Material and methods

Longitudinal prospective study of 60 patients with ocular hypertension or glaucoma who were treated with travoprost, or with a fixed combination of travoprost/timolol nightly. All subjects were given a Travalert^庐 dosing aid and were reviewed after one and four months. Strict and relative compliance data were collected on each visit. The relationship between compliance and other variables was studied using univariate analysis. To analyse quality of life, patients were given self-assessment STAI anxiety questionnaires after the first and last visits.

Results

Relative compliance for the four months was significantly greater than the strict compliance (P = .001). In the group of least compliance the number of patients on treatment with combination therapy was significantly higher than those on monotherapy. In the lost cases, the number of men was significantly higher than women. No association was found in the other variables. The anxiety was similar to that in the normal population.

Conclusions

Compliance is very important in the treatment of glaucoma, and our study provides objective data through the use of Travalert dosing aid with relative compliances of 70%. Patients with combined therapies have lower compliance than those on monotherapy.